Cite

HARVARD Citation

    Sheikh, S. et al. (n.d.). THU0305 Pharmacokinetics of Switching from Intravenous To Subcutaneous Belimumab for Patients with Systemic Lupus Erythematosus (SLE). Annals of the rheumatic diseases. pp. 297-298. [Online]. 
  
Back to record